Open AccessA highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
Author(s) -
Courtney Woolsey,
Robert W. Cross,
Krystle N. Agans,
Viktoriya Borisevich,
Daniel J. Deer,
Joan B. Geisbert,
Cheryl Gerardi,
Theresa Latham,
Karla A. Fenton,
Michael A. Egan,
John H. Eldridge,
Thomas W. Geisbert,
Demetrius Matassov
Publication year - 2022
Publication title -
plos neglected tropical diseases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.99
H-Index - 135
eISSN - 1935-2735
pISSN - 1935-2727
DOI - 10.1371/journal.pntd.0010433
Subject(s) - ebola vaccine , ebola virus , virology , marburg virus , vesicular stomatitis virus , filoviridae , immunogenicity , immunology , medicine , ebolavirus , virus , attenuated vaccine , immunity , immunization , mononegavirales , biology , antibody , immune system , viral disease , biochemistry , paramyxoviridae , virulence , gene